Thank you, Peter and welcome everyone. 2016 was a remarkable year for ASML, both financially and strategically. I would like to first highlight some of our financial accomplishments and then finish with our view of the coming quarter. 2016 was a record breaking year in many financial respects with total net sales, gross profit, net income and earnings per share all reaching record levels. In addition, we finished the year with the highest backlog ever, which combined with our current business view allows us to look forward to another great year in 2017. We are EUV becomes an integral and growing part of our system revenues, contributing significantly to our top-line growth through the balance of this decade and beyond. Turning to our Q4 results, net sales came in at EUR1.91 billion, net system sales accounted for EUR1.22 billion, driven by logic which represented 61% of net system sales with memory returning to strings versus Q3 accounting for 39% of net system sales. System sales included EUR144 million of EUV revenue, in line with the guidance given during our earnings call in October. Net service and field option sales for the quarter came in strong as expected at a level of EUR684 million, driven by ongoing strong demand for holistic lithography options, high value upgrades and our growing install base. Furthermore, we closed the acquisition of HMI in November and net service and field option sales includes about EUR25 million for this new and exciting part of our business. Our gross margin for the quarter came in at 47.2%. This includes starving the amortization of intangibles, as well as the effects from the fair value assessment of HMI’s inventory as of the closing date of the acquisition. The negative impact on gross margin for both of these purchase price allocation related items was approximately one percentage point. R&D expenses came in at EUR287 million, slightly higher than guided due to both the R&D expenses of HMI and the start of our partial funding of Zeiss SMT for our High-NA EUV program. SG&A expenses came in at EUR107 million also slightly higher than guided due to the inclusion of HMI. We also had an impact from foreign currency revaluations on transactions and balances relating to the HMI acquisition. You may remember that this was an unfavorable effect of about EUR28 million in Q3 as reported during our last call. For Q4, we had a more than offsetting favorable effect of about EUR83 million. These effects are reported in the interest and other line in our P&L. Moving to the order book. Q4 system booking s came in at EUR1.6 billion for 44 systems including six 3400 EUV systems. Strong bookings continued in the logic sector and support of the 10-nanometer RAMs and in support of EUV insertion at the seven nanometer node. Memory booking strengthened further from its strong Q3 level, supporting expected strength in memory shipments continuing in 2017, driven by DRAM. Continuing order flow for EUV systems brings our total year-end EUV system order book to 18 systems. Our overall systems backlog now stands at nearly EUR4 billion. Turning to the balance sheet. Quarter-over-quarter cash, cash equivalents and short-term investments came in at EUR4.06 billion. A major driver was our free cash flow of EUR1.1 billion in Q4. As we experienced in the last quarter of 2015, we saw a significant level of early payments from customers, which will impact Q1 2017 cash flows. Also as already mentioned before, we closed the HMI acquisition during the quarter and also issued a EUR750 million bond to support part of our planned strategic investment and Zeiss SMT, which is expected to close in Q2 of 2017. With that I would like to turn to our expectations and guidance for the first quarter of 2017. We expect continuing sales strengths in Q1 with total net sales of approximately EUR1.8 billion of which an estimated EUR30 million will be deferred EUV revenue. Foundry shipment strength supporting 10-nanometer RAMs will continue in Q1 and will be firmly supported by memory shipments. We also expect to ship our first NXE’s 3,400 EUV system in the quarter, we expect to record the revenue for the system in the third quarter of the year, since this system will ship in a non-final configuration. I would also like to mention here, that one of the EUV systems that we expected to ship early this year postponed from Q4 last year due to a customer readiness issue, will not ship this year as originally planned. Due to other exonerating circumstances, this customer has now decided to place a system upgrade order for this tool and will take delivery of it in 2108, where it will add to two other systems at the customer site to be shipped this year. This leaves our system output plan at 12 new systems and our shipment plan at 13 considering the one additional system that missed delivery for material availability reasons in Q4, 2016. We expect our Q1 service and field options revenue to again come in above EUR650 million driven by continued demand for holistic lithography options, high value upgrades and our growing installed base. For now, we will report HMI revenues under field options and services. But margins for Q1, is again expected to be around 47% including the effect from the purchase price allocation for the HMI acquisition. The negative impact of these purchase price allocation adjustment for Q1 is more than one percentage point. The impact for the full year, is about EUR90 million, and will reduce to about EUR40 million per year from 2018 onwards. R&D expenses for Q1, will be about EUR328 million and SG&A is expected to come in at about EUR95 million. The uptick in R&D spend is driven by the inclusion of HMI and accelerated investments in pattern fidelity metrology. Our contributions to SMT’s High-NA developments, our own High-NA development acceleration and the strong U.S. dollar. As a reminder, regarding our share buyback program, last year, we purchased EUR400 million worth of our own shares before the program was paused during our acquisition of HMI. It remains paused for the time being, as we closed our planned investment in Zeiss SMT. The transaction is in the regulatory approval process in the required jurisdictions. We’ve already received the approval in South Korea and expect the approval from Germany and China in time to close the transaction in Q2, 2017. And finally, an increase of our annual dividend from EUR1.05 to EUR1.20 will be proposed at our Annual General Meeting of shareholders in April. With that, I would like to turn the call back over to Peter.